Company intelligence / Profile preview
Lindis Biotech GmbH
Planegg/Martinsried, Bavaria, Germanylindisbiotech.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Lindis Biotech develops innovative immuno-oncology therapies based on its proprietary Triomab® platform. Its lead product catumaxomab was the first T-cell engaging multi-specific antibody approved worldwide. The company has three advanced clinical candidates targeting high unmet needs such as malignant ascites and non-muscle invasive bladder cancer. Recent licensing agreements aim to commercialize these assets further.
- Therapeutic areas
- Oncology
- Modalities
- Trifunctional bispecific antibodies (Triomab® platform)Monoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Pharmanovia – exclusive licensee/commercialization partner for catumaxomab in EuropeCelonic Group – manufacturing partner for commercial supply of catumaxomab
Beyond the preview
Go deeper on Lindis Biotech GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lindis Biotech GmbH.